These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1785311)

  • 81. Effect of growth hormone therapy on height in children with idiopathic short stature: a meta-analysis.
    Finkelstein BS; Imperiale TF; Speroff T; Marrero U; Radcliffe DJ; Cuttler L
    Arch Pediatr Adolesc Med; 2002 Mar; 156(3):230-40. PubMed ID: 11876666
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Growth hormone therapy in short stature.
    Knudtzon J; Aarskog D
    Pediatrician; 1987; 14(3):172-7. PubMed ID: 3331011
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Growth and metabolic consequences of growth hormone treatment in prepubertal short normal children.
    McCaughey ES; Mulligan J; Voss LD; Betts PR
    Arch Dis Child; 1994 Sep; 71(3):201-6. PubMed ID: 7979491
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Growth hormone therapy for short stature: panacea or Pandora's box?
    Allen DB; Fost NC
    J Pediatr; 1990 Jul; 117(1 Pt 1):16-21. PubMed ID: 2196357
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The psychosocial consequences of short stature: a review of the evidence.
    Sandberg DE; Voss LD
    Best Pract Res Clin Endocrinol Metab; 2002 Sep; 16(3):449-63. PubMed ID: 12464228
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Growth hormone therapy in children with short stature: is bigger better or achievable?
    Germak JA
    Indian J Pediatr; 1996; 63(5):591-7. PubMed ID: 10830027
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Effects of two years of methionyl growth hormone therapy in two dosage regimens in prepubertal children with short stature, subnormal growth rate, and normal growth hormone response to secretagogues. (Dutch Growth Hormone Working Group).
    Wit JM; Fokker MH; de Muinck Keizer-Schrama SM; Oostdijk W; Gons M; Otten BJ; Delemarre-Van de Waal HA; Reeser M; Waelkens JJ
    J Pediatr; 1989 Nov; 115(5 Pt 1):720-5. PubMed ID: 2809902
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Growth hormone treatment of Turner syndrome patients with insufficient growth hormone response to pharmacological stimulation tests.
    Massa G; Vanderschueren-Lodeweyckx M; Craen M; Vandeweghe M; van Vliet G
    Eur J Pediatr; 1991 May; 150(7):460-3. PubMed ID: 1915494
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Growth hormone treatment of short stature: status of the quality of life rationale.
    Sandberg DE; Colsman M
    Horm Res; 2005; 63(6):275-83. PubMed ID: 15983441
    [TBL] [Abstract][Full Text] [Related]  

  • 90. How far should indications for growth hormone treatment expand?
    Lancet; 1990 Mar; 335(8692):764. PubMed ID: 1969517
    [No Abstract]   [Full Text] [Related]  

  • 91. Idiopathic short stature: a clinical review.
    Cohen LE
    JAMA; 2014 May; 311(17):1787-96. PubMed ID: 24794372
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Acute and long-term responsiveness to growth hormone in children with short stature.
    Grunt JA; Enriquez AR
    Pediatr Res; 1972 Aug; 6(8):664-74. PubMed ID: 5053613
    [No Abstract]   [Full Text] [Related]  

  • 93. FDA approves growth hormone for short children.
    Child Health Alert; 2003 Sep; 21():4. PubMed ID: 14552287
    [No Abstract]   [Full Text] [Related]  

  • 94. [Growth hormone treatment of familial hypophosphatemic rickets].
    Saggese G; Baroncelli GI; Barsanti S
    Arch Pediatr; 1998; 5 Suppl 4():360S-363S. PubMed ID: 9853084
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Growth hormone treatment in short normal children.
    Bernasconi S; Volta C; Street ME; Mazzardo G; Ferzetti A; Iughetti L; Ghizzoni L
    J Pediatr Endocrinol Metab; 1996 Jun; 9 Suppl 3():339-43. PubMed ID: 8887179
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Is it ethical to treat healthy short children with growth hormone?
    Underwood LE; Rieser PA
    Acta Paediatr Scand Suppl; 1989; 362():18-23. PubMed ID: 2485593
    [No Abstract]   [Full Text] [Related]  

  • 97. How sociophenomenology of the body problematises the 'problem-oriented approach' to growth hormone treatment.
    Murano MC; Slatman J; Zeiler K
    Med Humanit; 2020 Mar; 46(1):2-11. PubMed ID: 30478090
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Is there an auxological basis for growth-promoting treatment with human growth hormone in short children?
    Ranke MB; Blank B
    Acta Paediatr Scand Suppl; 1990; 367():4-10. PubMed ID: 2220387
    [No Abstract]   [Full Text] [Related]  

  • 99. Should idiopathic short stature be treated with growth hormone?
    Savage MO
    Nat Clin Pract Endocrinol Metab; 2009 Mar; 5(3):148-9. PubMed ID: 19229234
    [No Abstract]   [Full Text] [Related]  

  • 100. Psychological impact of significantly short stature.
    Siegel PT; Clopper R; Stabler B
    Acta Paediatr Scand Suppl; 1991; 377():14-8; discussion 19. PubMed ID: 1785309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.